Analyst Price Target is $1.50
▲ +123.88% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Clover Health Investments in the last 3 months. The average price target is $1.50, with a high forecast of $1.50 and a low forecast of $1.50. The average price target represents a 123.88% upside from the last price of $0.67.
Current Consensus is
Hold
The current consensus among 1 contributing investment analysts is to hold stock in Clover Health Investments. This Hold consensus rating has held steady for over two years.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Read More